Pancreatic safety of vildagliptin in patients with type 2 diabetes mellitus: A European, noninterventional, postauthorization safety study

por Williams, Rachael, Kothny, Wolfgang, Serban, Carmen, Lopez‐Leon, Sandra, Schlienger, Raymond
Publicado 2019

Perinatal infections – a permanent challenge

por Rugină, Sorin, Dumitru, Irina Magdalena, Cernat, Roxana Carmen, Petcu, Andra, Ilie Șerban, Carmen
Publicado 2013

Association between vildagliptin and risk of angioedema, foot ulcers, skin lesions, hepatic toxicity, and serious infections in patients with type 2 diabetes mellitus: A European m...

por Williams, Rachael, Kothny, Wolfgang, Serban, Carmen, Lopez‐Leon, Sandra, de Vries, Frank, Schlienger, Raymond
Publicado 2019

Clostridium difficile colitis – a serious current problem

por Dumitru, Irina Magdalena, Dumitru, Eugen, Cernat, Roxana Carmen, Petcu, Andra Elena, Ilie Șerban, Carmen, Rugină, Sorin
Publicado 2013

Factors that may Account for Cardiovascular Risk Reduction with a Dipeptidyl Peptidase-4 Inhibitor, Vildagliptin, in Young Patients with Type 2 Diabetes Mellitus

por Evans, Marc, Kozlovski, Plamen, Paldánius, Päivi M., Foley, James E., Bhosekar, Vaishali, Serban, Carmen, Avogaro, Angelo
Publicado 2017

Clinical Safety and Tolerability of Vildagliptin — Insights from Randomised Trials, Observational Studies and Post-marketing Surveillance

por Mathieu, Chantal, Kozlovski, Plamen, Paldánius, Päivi M, Foley, James E, Modgill, Vikas, Evans, Marc, Serban, Carmen
Publicado 2017

Carbapenem-Resistant Klebsiella pneumoniae Associated with COVID-19

por Dumitru, Irina Magdalena, Dumitrascu, Mirela, Vlad, Nicoleta Dorina, Cernat, Roxana Carmen, Ilie-Serban, Carmen, Hangan, Aurelia, Slujitoru, Raluca Elena, Gherghina, Aura, Mitroi-Maxim, Corina, Curtali, Licdan, Carp, Dalia Sorina, Dumitrescu, Anca, Mitan, Romelia, Lesanu, Rodica, Rugina, Sorin
Publicado 2021